Allstate Corporation’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Buy
10,808
+234
+2% +$13.5K 0.01% 1035
2026
Q1
$695K Buy
+10,574
New +$552K 0.01% 924
2025
Q1
Sell
-3,245
Closed -$225K 592
2024
Q4
$225K Buy
+3,245
New +$312K 0.01% 616
2023
Q1
Sell
-7,496
Closed -$766K 258
2022
Q4
$766K Buy
7,496
+263
+4% +$26.1K 0.02% 411
2022
Q3
$653K Buy
+7,233
New +$794K 0.02% 435
2022
Q1
Sell
-15,587
Closed -$2.62M 615
2021
Q4
$2.62M Buy
+15,587
New +$2.54M 0.05% 325
2020
Q2
Sell
-10,537
Closed -$773K 676
2020
Q1
$773K Sell
10,537
-13,105
-55% -$1.3M 0.03% 260
2019
Q4
$2.91M Buy
23,642
+700
+3% +$86.2K 0.05% 222
2019
Q3
$2.81M Sell
22,942
-455
-2% -$51.3K 0.05% 219
2019
Q2
$2.52M Buy
23,397
+7
+0% +$725 0.05% 242
2019
Q1
$2.31M Buy
23,390
+480
+2% +$47.2K 0.06% 230
2018
Q4
$2.06M Buy
+22,910
New +$2.25M 0.07% 218

Other funds holding CE

Allstate Corporation's CE Position: Q2 2026 in Review

Allstate Corporation increased its Celanese (CE) stake by 2.2% in Q2 2026, buying an estimated $13.5K and bringing the position to 10,808 shares worth $497K. The position accounts for 0.01% of the portfolio, ranked #1035.

Allstate Corporation first reported a position in CE in Q4 2018 and has held it in 12 quarters since. The position peaked at $2.91M in Q4 2019. 460 funds tracked by Wall St. Rank hold CE as of Q2 2026.

  • Allstate Corporation held 10,808 shares of Celanese worth $497K as of Q2 2026.
  • Allstate Corporation bought 234 Celanese shares in Q2 2026, an estimated $13.5K.
  • Celanese made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #1035 holding.
  • Allstate Corporation first reported a position in Celanese in Q4 2018 and has held it in 12 quarters since.
  • Allstate Corporation's Celanese position peaked at $2.91M in Q4 2019.
  • 460 funds tracked by Wall St. Rank held Celanese as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.